We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Kenya is set to receive the first shipment of a new HIV/AIDS drug that could help patients whose treatment with first-line antiretrovirals (ARVs) has failed.
The U.S. National Institute of Allergy and Infectious Diseases, part of the NIH, has awarded the first installment of $2.4 million of a total amount of up to $8.5 million to Biota, a drug development company based in Melbourne, Australia.
The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has sent a letter to healthcare professionals about the prescribing of chloroflourocarbon (CFC)-free inhalers to treat asthma.
The Indian government is planning to expand the list of psychotropic substances that are allowed to be manufactured in the country for export purposes only.
Health Canada is warning consumers not to use the product Neophase Formula for Men, which has been found to contain an undeclared ingredient similar to the active pharmaceutical ingredient found in Viagra.
More antibiotic injection produced by a pharmaceutical company in east China's Anhui Province have been recalled as it is suspected to have killed three people, sources with the Anhui Provincial Food and Drug Bureau said.
Swiss drugmaker Roche Holding AG said Tuesday it has filed its top-selling drug Avastin to Europe's medical regulator, for approval for use as a treatment for the most common form of lung cancer.
One of Australia's most senior cancer specialists has accused pharmaceutical companies of manipulating some clinical trials of medicines for commercial reasons, including deliberately delaying the release of negative findings and being reluctant to fund research into the toxicity of their drugs.